CCM
GSK icon

Consolidated Capital Management’s GSK GSK Stock Holding History

Consolidated Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-4,728
Closed -$210K – 48
2017
Q4 		$210K Buy
+4,728
New +$218K 0.22% 51

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Consolidated Capital Management's GSK Position: Q1 2018 in Review

Consolidated Capital Management sold out of GSK (GSK) in Q1 2018, closing a stake of 4,728 shares — an estimated $210K sold.

Consolidated Capital Management first reported a position in GSK in Q4 2017 and held it in 1 quarter. The position peaked at $210K in Q4 2017. 778 funds tracked by Wall St. Rank hold GSK as of Q1 2018.

  • Consolidated Capital Management reported no remaining GSK position as of Q1 2018 after selling out during the quarter.
  • Consolidated Capital Management sold 4,728 GSK shares in Q1 2018, an estimated $210K.
  • Consolidated Capital Management first reported a position in GSK in Q4 2017 and held it in 1 quarter.
  • Consolidated Capital Management's GSK position peaked at $210K in Q4 2017.
  • 778 funds tracked by Wall St. Rank held GSK as of Q1 2018.

Based on Consolidated Capital Management's 13F filing for Q1 2018, filed 18 Apr 2018.